J. Eileen Bird

Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding

Pancras C. Wong, Dietmar Seiffert, J. Eileen Bird et al. · Science Translational Medicine · 2017 · 144 citations

Immunology, Pharmacotherapy, Platelet Aggregation +21

Ischemic acute renal failure and antioxidant therapy in the rat. The relation between glomerular and tubular dysfunction.

J. Eileen Bird, K Milhoan, Curtis B. Wilson et al. · Journal of Clinical Investigation · 1988 · 134 citations · Full text

Antioxidant Therapy, Renal Pathology, Renal Inflammation +16

Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.

N. C. Trippodo, Jeffrey A. Robl, Magdi M. Asaad et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 84 citations

Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: Murine Ortholog of the Fletcher Trait

J. Eileen Bird, Patricia L. Smith, Xinkang Wang et al. · Thrombosis and Haemostasis · 2012 · 82 citations

Immunology, Pathology, Plasma Kallikrein-deficient Mice +22

Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships

Kyoung Soon Kim, Ligang Qian, J. Eileen Bird et al. · Journal of Medicinal Chemistry · 1993 · 70 citations · Full text

Medicinal Chemistry, Novel Quinoxaline Heterocycle, Pharmacological Study +14